Search Result "hyperprolactinemia"
Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 1 Year: 2011 Page: 52-64
Author(s): Walter Milano, Cosimo Walter DAcunto, Michele De Rosa, Michela Festa, Luca Milano, Claudio Petrella, Anna Capasso
Screening Models For Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review
Ebook: Personalized Immunotherapy for Tumor Diseases and Beyond
Volume: 8 Year: 2020
Author(s): Prashant Tiwari,Sunil Kumar Dubey,Shweta Shrivastava,Pratap Kumar Sahu
Doi: 10.2174/97898114700801200801
Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 38-55
Author(s): Walter Milano,Chiara Colletti,Anna Capasso
Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review
Journal: Current Drug Safety
Volume: 12 Issue: 1 Year: 2017 Page: 19-21
Author(s): Subramoniam Madhusoodanan,Leah R. Steinberg,Alisa Coleman,Samuel Bavli
Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 30-37
Author(s): Domenico De Berardis,Michele Fornaro,Nicola Serroni,Stefano Marini,Monica Piersanti,Marilde Cavuto,Alessandro Valchera,Monica Mazza,Gabriella Girinelli,Felice Iasevoli,Giampaolo Perna,Giovanni Martinotti,Massimo Di Giannantonio
Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 4 Year: 2019 Page: 511-518
Author(s): Mohamed M. Aboelnaga,Eman H. Eladawy,Maha M. Elshafei,Nahed Abdullah,Moustafa El. Shaer
Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 230-240
Author(s): Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta, Massimo Di Giannantonio
Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients In vivo and In vitro
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 7 Year: 2019 Page: 975-984
Author(s): Maria L.H. Medel,Gabriela G. Reyes,Luz M. Porras,Arturo R. Bernal,Jesús S. Luna,Adolfo P. Garcia,Jacqueline Cordova,Adalberto Parra,Srinivas Mummidi,David Kershenobich,JoselÃn Hernández
Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
Journal: Current Neuropharmacology
Volume: 3 Issue: 1 Year: 2005 Page: 73-85
Author(s): W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig, J. Marksteiner
Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 1 Year: 2007 Page: 41-52
Author(s): Vincent Goffin, Estelle Tallet, Jean-Baptiste Jomain, Paul A. Kelly